5- and 6-glycosylation of transferrin in patients with Alzheimer's disease

Metabolic Brain Disease

Volumn 19, Issue 1-2, 2004, Pages 89-96

  Van Rensburg, Susan J ^a   Berman, Peter ^b   Potocnik, Felix ^a   MacGregor, Pam ^a   Hon, Dinie ^a   De Villiers, Nico ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Genecare Molecular Genetics   (South Africa)

Author keywords

Alzheimer's disease; Free radicals; Glycosylation; TfC2; Transferrin

Indexed keywords

ALCOHOL; PROTEIN ANTIBODY; TRANSFERRIN; FREE RADICAL; N ACETYLNEURAMINIC ACID;

ALZHEIMER DISEASE; BLOTTING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GLYCOSYLATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISOELECTRIC FOCUSING; MOLECULE; SIALYLATION; ALCOHOLISM; ARTICLE; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION;

ALCOHOLISM; ALZHEIMER DISEASE; FREE RADICALS; GLYCOSYLATION; HETEROZYGOTE; HOMOZYGOTE; HUMANS; ISOELECTRIC FOCUSING; N-ACETYLNEURAMINIC ACID; OXIDATION-REDUCTION; TRANSFERRIN;

EID: 3242723458     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000027420.50736.62     Document Type: Conference Paper

References (27)

1. Beckman, L., and Beckman, G. (1986a). Transfetrin C2 as an enhancer of cyto- and genotoxic damage. Prog. Clin. Biol. Res. 209B:221-224.
2. Beckman, L., and Beckman, G. (1986b). Decrease of transfenin C2 frequency with age. Hum. Hered. 36:254-255.
3. de Jong, G., van Noort, W.L., Feelders, R.A., de Jeu-Jaspars, C.M., and van Eijk, H.G. (1992b). Adaptation of transferrin protein and glycan synthesis. Clin. Chim. Acta 212:27-45.
4. de Jong, G., van Noort, W.L., and van Eijk, H.G. (1992). Carbohydrate analysis of transferrin subfractions isolated by preparative isoelectric focusing in immobilized pH gradients. Electrophoresis 13:225-228.
5. Feelders, R.A., Vreugdenhil, G., de Jong, G., Swaak, A.J., and van Eijk, H.G. (1992). Transferrin microheterogeneity in rheumatoid arthritis. Relation with disease activity and anemia of chronic disease. Rheumatol. Int. 12:195-199.
6. Helander, A., Eriksson, G., Stibler, H., and Jeppsson, J.O. (2001). Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin. Chem. 47:1225-1233.
7. Hoefkens, P., Huijskes-Heins, M.I., de Jeu-Jaspars, C.M., van Noort, W.L., van Eijk, H.G. (1997). Influence of transferrin glycans on receptor binding and iron-donation. Glycoconj. J. 14:289-295.
8. Hu, W.L., Chindemi, P.A., and Regoeczi, E. (1992). In vivo behaviour of rat transferrin bearing a hybrid glycan and its interaction with macrophages. Biochem. Cell Biol. 70:636-642.
9. Lawrence, C.M., Ray, S., Babyonyshev, M., Galluser, R., Borhani, D.W., and Harrison, S.C. (1999). Crystal structure of the ectodomain of human transferrin receptor. Science 286:779-782.
10. Maeder, D.L. (1997). Geltrak: Gel Analysis Software for Windows, University of Maryland Biotechnology Institute, Baltimore. http://bix.umbi.umd. edu/maeder/Software/
11. Mason, A.B., Miller, M.K., Funk, W.D., Banfield, D.K., Savage, K.J., Oliver, R.W., Green, B.N., MacGillivray, R.T., and Woodworm, R.C. (1993). Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrins. Biochemistry 32:5472-5479.
12. Mc Ilroy, S.P., Curran, M.D., Dynan, K.D., Vahidassr, M.D., Gleenon, B.M., Lawson, J.T., Middleton, M., and Passmore, A.P. (2000). Genetic association of transferrin, but not the transferrin receptor or HFE with sporadic Alzheimer's. J. Alzheimer's Dis. 2:347.
13. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16:1215.
14. Nagaoka, M.H., and Maitani, T. (2001). Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS. Biochim. Biophys. Acta 1526:175-182.
15. Namekata, K., Imagawa, M., Terashi, A., Ohta, S., Oyama, F., and Ihara, Y. (1997). Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum. Genet. 101:126-129.
16. Padda, J.S., and Schryvers, A.B. (1990). N-linked oligosaccharides of human transferrin are not required for binding to bacterial transferrin receptors. Infect. Immun. 58:2972-2976.
17. Pearl, P.L., and Krasnewich, D. (2001). Neurologic course of congenital disorders of glycosylation. J. Child Neurol. 16:409-413.
18. Regoeczi, E., Bolyos, M., and Chindemi, P.A. (1989). Rat aglycotransferrin and human monoglycotransferrin: Production and metabolic properties. Arch. Biochem. Biophys. 268:637-642.
19. Sacks, D.B. (2001). Carbohydrates. In (C.A. Burtis and E.R. Ashwood, eds.), Tietz Fundamentals of Clinical Chemistry, 5th edn., W.B. Saunders, Philadelphia, p. 430.
20. van Kamp, G.J., Mulder, K., Kuiper, M., and Wolters, E.C. (1995). Changed transferrin sialylation in Parkinson's disease. Clin. Chim. Acta 235:159-167.
21. Van Landeghem, G.F., Sikström, C., Beckman, L.E., Adolfsson, R., and Beckman, L. (1998). Transferrin C2, metal binding and Alzheimer's disease. Neuroreport 9:177-179.
22. Van Rensburg, S.J., Berman, P.A., Potocnik, F.C.V., and Taljaard, J.J.F. (2000a). Glycosylation of transferrin in Alzheimer's disease and alcohol-induced dementia. Metabol. Brain Dis. 15:243-247.
23. Van Rensburg, S.J., Potocnik, F.C.V., de Villiers, J.N.P., Kotze, M.J., and Taljaard, J.J.F. (2000b). Earlier age of onset of Alzheimer's disease in patients with both the Transferrin C2 and Apolipoprotein E-ε4 alleles. Ann. N.Y. Acad. Sci. 903:200-203.
24. Wada, I., Kai, M., Imai, S., Sakane, F., and Kanoh, H. (1997). Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin. EMBO J. 16:5420-5432.
25. Wong, C.T., and Saha, N. (1986). Effects of transferrin genetic phenotypes on total iron-binding capacity. Acta haemat. 75:215-218.
26. Wu, Y., Swulius, M.T., Moremen, K.W., and Sifers, R.N. (2003). Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation. Proc. Natl. Acad. Sci. U.S.A. 100:8229-8234.
27. Wuyts, B., Delanghe, J.R., Kasvosve, I., Gordeuk, V.R., Gangaidzo, I.T., Gomo, Z.A. (2001). Carbohydrate-deficient transferrin and chronic alcohol ingestion in subjects with transferrin CD-variants. Clin. Chem. Lab. Med. 39:937-943.